SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients

SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients

Type 2 diabetes mellitus (T2DM) is the cause of the development of diabetic nephropathy — a complication that determines the high degree of disability and mortality of such patients. Until recently, approaches to normalizing glucose levels did not have a significant possibility of influencing the ou...

Full description

Bibliographic Details
Main Authors: Vladimir V Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Sergey I. Popov
Format: Article
Language:English
Published: Endocrinology Research Centre 2021-01-01
Series:Сахарный диабет
Subjects:
type 2 diabetes mellitus
diabetic nephropathy
end-stage renal disease
albuminuria
glomerular filtration rate
nephroprotection
type 2 sodium glucose cotransporter inhibitors
Online Access:https://www.dia-endojournals.ru/jour/article/view/12123

Internet

https://www.dia-endojournals.ru/jour/article/view/12123

Similar Items